Table 2.
Differences in longitudinal quality of life (QoL) assessed by SF36 and FACT-BMT Form between HID and MSD patients
| QoL | HSCT (HID vs. MSD) | Time (months post-HSCT) | ||
|---|---|---|---|---|
| β (95% CI) a | P | β (95% CI) a | P | |
| SF-36 | ||||
| GH | 5.46 (0.62, 10.29) | 0.027b | 0.03 (− 0.15, 0.22) | 0.722 |
| PF | 2.83 (− 3.15, 8.82) | 0.353 | 0.30 (0.07, 0.52) | 0.011b |
| RP | 4.06 (− 1.83, 9.94) | 0.177 | 0.82 (0.44, 1.20) | < 0.001b |
| RE | 4.83 (− 4.41, 14.08) | 0.306 | 0.33 (-0.10, 0.76) | 0.129 |
| SF | 4.21 (− 2.08, 10.51) | 0.190 | 0.68 (0.41, 0.94) | < 0.001b |
| BP | 4.06 (− 0.79, 8.91) | 0.101 | 0.09 (− 0.09, 0.27) | 0.336 |
| VT | 6.18 (1.37, 11.00) | 0.012b | 0.12 (− 0.05, 0.29) | 0.168 |
| MH | 4.53 (0.38, 8.68) | 0.032b | − 0.07 (− 0.20, 0.08) | 0.333 |
| FACT-BMT | ||||
| PWB | 1.49 (0.11, 2.87) | 0.034b | 0.09 (0.04, 0.14) | < 0.001b |
| SWB | 1.29 (0.21, 2.38) | 0.020b | − 0.05 (− 0.10, 0.01) | 0.099 |
| EWB | 0.47 (− 0.57, 1.50) | 0.378 | − 0.01 (− 0.04, 0.02) | 0.482 |
| FWB | 1.89 (0.52, 3.26) | 0.007b | 0.02 (− 0.06, 0.10) | 0.560 |
| FACT-G | 5.34 (1.72, 8.76) | 0.004b | 0.05 (− 0.11, 0.20) | 0.545 |
| TOI | 2.80 (0.43, 5.18) | 0.021b | 0.09 (− 0.01, 0.19) | 0.095 |
| FACT-BMT | 4.64 (1.09, 8.19) | 0.010b | 0.03 (− 0.12, 0.17) | 0.727 |
GH general health, PF physical functioning, RP role physical, RE role emotional, SF social functioning, BP bodily pain, VT vitality, MH mental health, PWB physical well-being, FWB functional well-being, SWB social well-being, EWB emotional well-being, FACT-BMT total with BMT module, TOI, FACT-BMT Trial Outcome Index (TOI)
aModel adjusted for age, sex, education, body mass index (BMI), main caregivers, diagnosis, transplantation type, history of aGVHD and cGVHD, and history of infection
bIndicates the statistical significance for the factors